These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8292724)

  • 21. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
    Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
    Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes.
    Brinkman HJ; Mertens K; Holthuis J; Zwart-Huinink LA; Grijm K; van Mourik JA
    Br J Haematol; 1994 Jun; 87(2):332-42. PubMed ID: 7947276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid.
    Barrowcliffe TW; Fábregas P; Jardi M; Cancelas J; Rabaneda M; Felez J
    Thromb Haemost; 2002 Mar; 87(3):442-9. PubMed ID: 11916077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.
    Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT
    J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the interaction between factor Xa and bovine aortic endothelial cells.
    Rodgers GM; Shuman MA
    Biochim Biophys Acta; 1985 Mar; 844(3):320-9. PubMed ID: 3970981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of endothelium in the homeostatic balance of haemostasis.
    Nawroth P; Kisiel W; Stern D
    Clin Haematol; 1985 Jun; 14(2):531-46. PubMed ID: 2994930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins.
    Oslakovic C; Krisinger MJ; Andersson A; Jauhiainen M; Ehnholm C; Dahlbäck B
    J Biol Chem; 2009 Feb; 284(9):5896-904. PubMed ID: 19129179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
    Estry DW; Tishkoff GH
    Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the organization of membrane lipids during human platelet activation. Study by fluorescent and freeze-fracture cytochemistry.
    Lupu F; Calb M; Scurei C; Simionescu N
    Lab Invest; 1986 Feb; 54(2):136-45. PubMed ID: 3945048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa.
    Tijburg PN; Ryan J; Stern DM; Wollitzky B; Rimon S; Rimon A; Handley D; Nawroth P; Sixma JJ; de Groot PG
    J Biol Chem; 1991 Jun; 266(18):12067-74. PubMed ID: 2050700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catabolism of rabbit prothrombin in rabbits: uptake of prothrombin by the aorta wall before and after a de-endothelializing injury in vivo.
    Hatton MW; Southward SM; Serebrin SD; Kulczycky M; Blajchman MA
    J Lab Clin Med; 1995 Dec; 126(6):521-9. PubMed ID: 7490511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro.
    Biedermann B; Rosenmund A; Muller M; Kohler HP; Haeberli A; Straub PW
    J Lab Clin Med; 1994 Sep; 124(3):339-47. PubMed ID: 8083577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.